Data supplements
Supplemental Data
Files in this Data Supplement:
Jump to section
- Article
- Abstract
- NUMBER OF 123I-MIBG STUDIES IN JAPAN
- CLINICAL USE OF 123I-MIBG STUDIES LEADING TO JAPANESE NUCLEAR CARDIOLOGY GUIDELINES
- RECOMMENDED PROTOCOLS IN JAPAN
- NORMAL VALUES AND STANDARDIZATION
- INCREMENTAL CLINICAL BENEFITS OF CARDIAC 123I-MIBG IMAGING FOR HF
- PHARMACOLOGIC TREATMENT AND CARDIAC 123I-MIBG IMAGING
- NEED FOR NEW RISK STRATIFICATION METHOD FOR DEVICE TREATMENT
- DEVICE TREATMENT AND CARDIAC 123I-MIBG IMAGING
- CARDIAC 123I-MIBG IMAGING IN HEART TRANSPLANTATION
- IDENTIFICATION OF LOW-RISK PATIENTS WITH HF
- LIMITATIONS AND FUTURE DIRECTIONS OF CARDIAC 123I-MIBG IMAGING
- DISCLOSURE
- Acknowledgments
- Footnotes
- REFERENCES
- Figures & Data
- Supplemental
- Info & Metrics
Related Articles
Cited By...
- Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
- Plasma biomarkers of neurodegeneration in patients with Parkinsons disease and dementia with Lewy bodies and at-risk individuals of Lewy body disease in the NaT-PROBE cohort
- Autopsy Validation of the Diagnostic Accuracy of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
- Simplified Quantification and Acquisition Protocol for 123I-MIBG Dynamic SPECT
- Impact of Novel Antidepressants on Cardiac 123I-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits
- Quantitative Analysis of Dynamic 123I-mIBG SPECT Imaging Data in Healthy Humans with a Population-Based Metabolite Correction Method